Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115830) titled 'Development and Application Verification of LLM Based Stroke Intelligent Health Rivisit Mangage System' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xuanwu Hospital Capital Medical University
Condition:
Stroke
I64.X04
Intervention:
Intervention group:Rivisit management for stroke patients via stroke intelligent health rivisit mangage system, includes blood pressure monitor, stroke symptom assess, compliance monitor of drug usage and physical activity encouragement
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-01-26
Target Sa...